Lambert-Eaton Myasthenic Syndrome Caused by Atezolizumab in a Patient with Small-cell Lung Cancer

We herein report a 74-year-old man who developed Lambert-Eaton myasthenic syndrome (LEMS) during atezolizumab treatment for extensive-stage small-cell lung cancer. He was started on maintenance immunotherapy with atezolizumab every three weeks after four cycles of atezolizumab plus carboplatin plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunii, Eiji, Owaki, Sota, Yamada, Kazuki, Yoshihara, Misuzu, Yamaba, Yusuke, Takakuwa, Osamu, Toyoda, Takanari, Akita, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259317/
https://www.ncbi.nlm.nih.gov/pubmed/34707051
http://dx.doi.org/10.2169/internalmedicine.8387-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259317/
https://www.ncbi.nlm.nih.gov/pubmed/34707051
http://dx.doi.org/10.2169/internalmedicine.8387-21

Ejemplares similares